tirzepatide for maintenance Low-Dose Maintenance: Guide to Long-Term Weight Control People Who Stopped Taking the

Dosis de inicio y mxima SC DM2: 0,25 mg/sem mantenimiento 0,52 mg/sem

GLUTATHIONE IN ENDOPLASMIC RETICULUM In ER, glutathione exists mainly as oxidized glutathione (GSSG)

Phase 2 Trial Design Participants: 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27), without diabetes Duration: 48 weeks Dosing groups: Placebo, 1mg, 4mg, 8mg, or 12mg weekly (with gradual dose escalation over 20-24 weeks) Primary endpoint: Percentage change in body weight from baseline Beyond Weight Loss: Metabolic Improvements Beyond weight loss, the 12mg dose also improved several cardiometabolic markers: Blood pressure: Systolic BP decreased by 7.4 mmHg (clinically significant reduction) Lipids: Triglycerides fell 30%, HDL cholesterol increased 8% Glucose control: HbA1c decreased 0.4% even in participants without diabetes Liver health: Markers of fatty liver disease (ALT, AST) improved significantly Inflammation: C-reactive protein (CRP) decreased, indicating reduced systemic inflammation What this means: Retatrutide appears to improve the metabolic dysfunction behind obesity-related diseases, not just the weight itself

10.1007/s11033-014-3832-z[Epub ahead of print]

I had Covid-19 recently and this has knocked me about

Being Patient: For Alzheimers prevention, maybe it will just be one piece of that puzzle, right